Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era

Saleh Elwir, Chimaobi Anugwom, Esther K. Connor, Nasra H. Giama, Albert Ndzengue, Jeremiah Menk, Essa A. Mohamed, Lewis R. Roberts, Mohamed Hassan

Research output: Contribution to journalArticle

Abstract

Background and aims: Hepatitis C virus (HCV) treatment has changed dramatically in the last few years. Our observations suggest that a minority of HCV infected Somalis are treated. In this study, we aimed to evaluate for treatment and health outcome disparities between Somali and non-Somali patients during the direct acting antiviral (DAA) era. Methods: Patients with HCV seen in the gastroenterology clinic in 2015 were included in the study. Patients were identified using ICD9 and 10 codes. Electronic medical records were analyzed to evaluate for treatment candidacy, acceptance and reasons for refusal of treatment. Results: Genotype 4 followed by 3 were the most common genotypes in the Somalis while genotype 1 was the most common in the non-Somalis. Majority of patients were offered treatment, active alcohol and substance abuse was a common reason for not offering treatment in non-Somalis while the presence of hepatocellular carcinoma was the most common reason in Somalis. Somalis had higher rates of declining treatment given the asymptomatic nature of their disease and the feeling that treatment is not needed. Sustained virologic response rates were comparable in both groups. Conclusions: Disparities in acceptance of HCV treatment persist in the DAA era. The asymptomatic nature of the infection and potential cultural mistrust makes patients hesitant to undergo treatment. Healthcare providers must find interventions aimed at reducing barriers to treatment and increasing acceptance of HCV treatment.

Original languageEnglish (US)
Pages (from-to)556-559
Number of pages4
JournalJournal of the National Medical Association
Volume110
Issue number6
DOIs
StatePublished - Dec 2018

Keywords

  • Health Disparity
  • Hepatitis C
  • Somali

Fingerprint Dive into the research topics of 'Barriers in Hepatitis C Treatment in Somali Patients in the Direct Acting Antiviral Therapy Era'. Together they form a unique fingerprint.

  • Cite this